Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0
Identifieur interne : 004208 ( Main/Exploration ); précédent : 004207; suivant : 004209Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0
Auteurs : Maarten Boers [Pays-Bas] ; John R. Kirwan [Royaume-Uni] ; George Wells [Canada] ; Dorcas Beaton [Canada] ; Laure Gossec [France] ; Maria-Antonietta D'Agostino [France] ; Philip G. Conaghan [Royaume-Uni] ; Clifton O. Iii Bingham [États-Unis] ; Peter Brooks [Australie] ; Robert Landewe [Pays-Bas] ; Lyn March [Australie] ; Lee S. Simon [États-Unis] ; Jasvinder A. Singh [États-Unis] ; Vibeke Strand [États-Unis] ; Peter Tugwell [Canada]Source :
- Journal of clinical epidemiology [ 0895-4356 ] ; 2014.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Recherche scientifique, Norme, Médecine, Santé publique, Soins de santé.
English descriptors
- KwdEn :
Abstract
Background: Lack of standardization of outcome measures limits the usefulness of clinical trial evidence to inform health care decisions. This can be addressed by agreeing on a minimum core set of outcome measures per health condition, containing measures relevant to patients and decision makers. Since 1992, the Outcome Measures in Rheumatology (OMERACT) consensus initiative has successfully developed core sets for many rheumatologic conditions, actively involving patients since 2002. Its expanding scope required an explicit formulation of its underlying conceptual framework and process. Methods: Literature searches and iterative consensus process (surveys and group meetings) of stakeholders including patients, health professionals, and methodologists within and outside rheumatology. Results: To comprehensively sample patient-centered and intervention-specific outcomes, a framework emerged that comprises three core "Areas," namely Death, Life Impact, and Pathophysiological Manifestations; and one strongly recommended Resource Use. Through literature review and consensus process, core set development for any specific health condition starts by identifying at least one core "Domain" within each of the Areas to formulate the "Core Domain Set." Next, at least one applicable measurement instrument for each core Domain is identified to formulate a "Core Outcome Measurement Set." Each instrument must prove to be truthful (valid), discriminative, and feasible. In 2012, 96% of the voting participants (n = 125) at the OMERACT 11 consensus conference endorsed this model and process. Conclusion: The OMERACT Filter 2.0 explicitly describes a comprehensive conceptual framework and a recommended process to develop core outcome measurement sets for rheumatology likely to be useful as a template in other areas of health care.
Affiliations:
- Australie, Canada, France, Pays-Bas, Royaume-Uni, États-Unis
- Angleterre, Hollande-Septentrionale, Nouvelle-Galles du Sud, Ontario, Victoria (État), Yorkshire-et-Humber, Île-de-France
- Amsterdam, Boulogne-Billancourt, Leeds, Melbourne, Paris, Sydney, Toronto
- Université Pierre-et-Marie-Curie, Université d'Amsterdam, Université de Leeds, Université de Melbourne, Université de Sydney, Université de Toronto
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000272
- to stream PascalFrancis, to step Curation: 005B90
- to stream PascalFrancis, to step Checkpoint: 000353
- to stream Main, to step Merge: 004277
- to stream Main, to step Curation: 004208
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0</title><author><name sortKey="Boers, Maarten" sort="Boers, Maarten" uniqKey="Boers M" first="Maarten" last="Boers">Maarten Boers</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Epidemiology and Biostatistics, VU University Medical Center, PK 6Z 165, PO Box 7057</s1><s2>1007 MB Amsterdam</s2><s3>NLD</s3><sZ>1 aut.</sZ></inist:fA14><country>Pays-Bas</country><wicri:noRegion>1007 MB Amsterdam</wicri:noRegion></affiliation></author><author><name sortKey="Kirwan, John R" sort="Kirwan, John R" uniqKey="Kirwan J" first="John R." last="Kirwan">John R. Kirwan</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary</s1><s2>Bristol</s2><s3>GBR</s3><sZ>2 aut.</sZ></inist:fA14><country>Royaume-Uni</country><wicri:noRegion>Bristol</wicri:noRegion></affiliation></author><author><name sortKey="Wells, George" sort="Wells, George" uniqKey="Wells G" first="George" last="Wells">George Wells</name><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Epidemiology and Community Medicine, University of Ottawa</s1><s2>Ottawa, Ontario</s2><s3>CAN</s3><sZ>3 aut.</sZ></inist:fA14><country>Canada</country><wicri:noRegion>Ottawa, Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Beaton, Dorcas" sort="Beaton, Dorcas" uniqKey="Beaton D" first="Dorcas" last="Beaton">Dorcas Beaton</name><affiliation wicri:level="4"><inist:fA14 i1="04"><s1>Department of Occupational Science and Occupational Therapy, University of Toronto</s1><s2>Toronto, Ontario</s2><s3>CAN</s3><sZ>4 aut.</sZ></inist:fA14><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName><orgName type="university">Université de Toronto</orgName></affiliation></author><author><name sortKey="Gossec, Laure" sort="Gossec, Laure" uniqKey="Gossec L" first="Laure" last="Gossec">Laure Gossec</name><affiliation wicri:level="4"><inist:fA14 i1="05"><s1>Department of Rheumatology, Université Pierre et Marie Curie (UPMC), Paris 6, GRC-UMPC 08 (EEMOIS), and Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière</s1><s2>Paris</s2><s3>FRA</s3><sZ>5 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement><settlement type="city">Paris</settlement></placeName><orgName type="university">Université Pierre-et-Marie-Curie</orgName></affiliation></author><author><name sortKey="D Agostino, Maria Antonietta" sort="D Agostino, Maria Antonietta" uniqKey="D Agostino M" first="Maria-Antonietta" last="D'Agostino">Maria-Antonietta D'Agostino</name><affiliation wicri:level="3"><inist:fA14 i1="06"><s1>Department of Rheumatology, Université Versailles-Saint Quentin en Yvelines, Ambroise Pare Hospital</s1><s2>Boulogne-Billancourt</s2><s3>FRA</s3><sZ>6 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Boulogne-Billancourt</settlement></placeName></affiliation></author><author><name sortKey="Conaghan, Philip G" sort="Conaghan, Philip G" uniqKey="Conaghan P" first="Philip G." last="Conaghan">Philip G. Conaghan</name><affiliation wicri:level="4"><inist:fA14 i1="07"><s1>NIHR Leeds Musculoskeletal Biomedical Research Unit, University of Leeds</s1><s2>Leeds</s2><s3>GBR</s3><sZ>7 aut.</sZ></inist:fA14><country>Royaume-Uni</country><placeName><settlement type="city">Leeds</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Yorkshire-et-Humber</region></placeName><orgName type="university">Université de Leeds</orgName></affiliation></author><author><name sortKey="Bingham, Clifton O Iii" sort="Bingham, Clifton O Iii" uniqKey="Bingham C" first="Clifton O. Iii" last="Bingham">Clifton O. Iii Bingham</name><affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Division of Rheumatology, Johns Hopkins University</s1><s2>Baltimore, MD 21224</s2><s3>USA</s3><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>Baltimore, MD 21224</wicri:noRegion></affiliation></author><author><name sortKey="Brooks, Peter" sort="Brooks, Peter" uniqKey="Brooks P" first="Peter" last="Brooks">Peter Brooks</name><affiliation wicri:level="4"><inist:fA14 i1="09"><s1>School of Population and Global Health, University of Melbourne</s1><s2>Melbourne</s2><s3>AUS</s3><sZ>9 aut.</sZ></inist:fA14><country>Australie</country><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region><settlement type="city">Melbourne</settlement></placeName><orgName type="university">Université de Melbourne</orgName></affiliation></author><author><name sortKey="Landewe, Robert" sort="Landewe, Robert" uniqKey="Landewe R" first="Robert" last="Landewe">Robert Landewe</name><affiliation wicri:level="4"><inist:fA14 i1="10"><s1>Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam</s1><s2>Amsterdam</s2><s3>NLD</s3><sZ>10 aut.</sZ></inist:fA14><country>Pays-Bas</country><placeName><settlement type="city">Amsterdam</settlement><region nuts="2" type="province">Hollande-Septentrionale</region><settlement type="city">Amsterdam</settlement></placeName><orgName type="university">Université d'Amsterdam</orgName></affiliation></author><author><name sortKey="March, Lyn" sort="March, Lyn" uniqKey="March L" first="Lyn" last="March">Lyn March</name><affiliation wicri:level="4"><inist:fA14 i1="11"><s1>Institute of Bone and Joint Research, Kolling Institute of Medical Research, University of Sydney</s1><s2>Sydney</s2><s3>AUS</s3><sZ>11 aut.</sZ></inist:fA14><country>Australie</country><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region><settlement type="city">Sydney</settlement></placeName><orgName type="university">Université de Sydney</orgName></affiliation><affiliation wicri:level="1"><inist:fA14 i1="12"><s1>Department of Rheumatology, Royal North Shore Hospital, St. Leonards</s1><s2>New South Wales</s2><s3>AUS</s3><sZ>11 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>New South Wales</wicri:noRegion></affiliation></author><author><name sortKey="Simon, Lee S" sort="Simon, Lee S" uniqKey="Simon L" first="Lee S." last="Simon">Lee S. Simon</name><affiliation wicri:level="1"><inist:fA14 i1="13"><s1>SDG LLC</s1><s2>Cambridge, MA 02138</s2><s3>USA</s3><sZ>12 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>SDG LLC</wicri:noRegion></affiliation></author><author><name sortKey="Singh, Jasvinder A" sort="Singh, Jasvinder A" uniqKey="Singh J" first="Jasvinder A." last="Singh">Jasvinder A. Singh</name><affiliation wicri:level="1"><inist:fA14 i1="14"><s1>Division of Rheumatology, University of Alabama at Birmingham</s1><s2>Birmingham, AL 35294</s2><s3>USA</s3><sZ>13 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>Birmingham, AL 35294</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="15"><s1>Veterans Affairs Medical Center</s1><s2>Birmingham, AL 35294</s2><s3>USA</s3><sZ>13 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>Veterans Affairs Medical Center</wicri:noRegion></affiliation></author><author><name sortKey="Strand, Vibeke" sort="Strand, Vibeke" uniqKey="Strand V" first="Vibeke" last="Strand">Vibeke Strand</name><affiliation wicri:level="1"><inist:fA14 i1="16"><s1>Division of Immunology/Rheumatology, Stanford University School of Medicine</s1><s2>Palo Alto, CA 94028</s2><s3>USA</s3><sZ>14 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>Palo Alto, CA 94028</wicri:noRegion></affiliation></author><author><name sortKey="Tugwell, Peter" sort="Tugwell, Peter" uniqKey="Tugwell P" first="Peter" last="Tugwell">Peter Tugwell</name><affiliation wicri:level="1"><inist:fA14 i1="17"><s1>Department of Medicine, University of Ottawa</s1><s2>Ottawa, Ontario</s2><s3>CAN</s3><sZ>15 aut.</sZ></inist:fA14><country>Canada</country><wicri:noRegion>Ottawa, Ontario</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">14-0220648</idno><date when="2014">2014</date><idno type="stanalyst">PASCAL 14-0220648 INIST</idno><idno type="RBID">Pascal:14-0220648</idno><idno type="wicri:Area/PascalFrancis/Corpus">000272</idno><idno type="wicri:Area/PascalFrancis/Curation">005B90</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000353</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000353</idno><idno type="wicri:doubleKey">0895-4356:2014:Boers M:developing:core:outcome</idno><idno type="wicri:Area/Main/Merge">004277</idno><idno type="wicri:Area/Main/Curation">004208</idno><idno type="wicri:Area/Main/Exploration">004208</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0</title><author><name sortKey="Boers, Maarten" sort="Boers, Maarten" uniqKey="Boers M" first="Maarten" last="Boers">Maarten Boers</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Epidemiology and Biostatistics, VU University Medical Center, PK 6Z 165, PO Box 7057</s1><s2>1007 MB Amsterdam</s2><s3>NLD</s3><sZ>1 aut.</sZ></inist:fA14><country>Pays-Bas</country><wicri:noRegion>1007 MB Amsterdam</wicri:noRegion></affiliation></author><author><name sortKey="Kirwan, John R" sort="Kirwan, John R" uniqKey="Kirwan J" first="John R." last="Kirwan">John R. Kirwan</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary</s1><s2>Bristol</s2><s3>GBR</s3><sZ>2 aut.</sZ></inist:fA14><country>Royaume-Uni</country><wicri:noRegion>Bristol</wicri:noRegion></affiliation></author><author><name sortKey="Wells, George" sort="Wells, George" uniqKey="Wells G" first="George" last="Wells">George Wells</name><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Epidemiology and Community Medicine, University of Ottawa</s1><s2>Ottawa, Ontario</s2><s3>CAN</s3><sZ>3 aut.</sZ></inist:fA14><country>Canada</country><wicri:noRegion>Ottawa, Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Beaton, Dorcas" sort="Beaton, Dorcas" uniqKey="Beaton D" first="Dorcas" last="Beaton">Dorcas Beaton</name><affiliation wicri:level="4"><inist:fA14 i1="04"><s1>Department of Occupational Science and Occupational Therapy, University of Toronto</s1><s2>Toronto, Ontario</s2><s3>CAN</s3><sZ>4 aut.</sZ></inist:fA14><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName><orgName type="university">Université de Toronto</orgName></affiliation></author><author><name sortKey="Gossec, Laure" sort="Gossec, Laure" uniqKey="Gossec L" first="Laure" last="Gossec">Laure Gossec</name><affiliation wicri:level="4"><inist:fA14 i1="05"><s1>Department of Rheumatology, Université Pierre et Marie Curie (UPMC), Paris 6, GRC-UMPC 08 (EEMOIS), and Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière</s1><s2>Paris</s2><s3>FRA</s3><sZ>5 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement><settlement type="city">Paris</settlement></placeName><orgName type="university">Université Pierre-et-Marie-Curie</orgName></affiliation></author><author><name sortKey="D Agostino, Maria Antonietta" sort="D Agostino, Maria Antonietta" uniqKey="D Agostino M" first="Maria-Antonietta" last="D'Agostino">Maria-Antonietta D'Agostino</name><affiliation wicri:level="3"><inist:fA14 i1="06"><s1>Department of Rheumatology, Université Versailles-Saint Quentin en Yvelines, Ambroise Pare Hospital</s1><s2>Boulogne-Billancourt</s2><s3>FRA</s3><sZ>6 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Boulogne-Billancourt</settlement></placeName></affiliation></author><author><name sortKey="Conaghan, Philip G" sort="Conaghan, Philip G" uniqKey="Conaghan P" first="Philip G." last="Conaghan">Philip G. Conaghan</name><affiliation wicri:level="4"><inist:fA14 i1="07"><s1>NIHR Leeds Musculoskeletal Biomedical Research Unit, University of Leeds</s1><s2>Leeds</s2><s3>GBR</s3><sZ>7 aut.</sZ></inist:fA14><country>Royaume-Uni</country><placeName><settlement type="city">Leeds</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Yorkshire-et-Humber</region></placeName><orgName type="university">Université de Leeds</orgName></affiliation></author><author><name sortKey="Bingham, Clifton O Iii" sort="Bingham, Clifton O Iii" uniqKey="Bingham C" first="Clifton O. Iii" last="Bingham">Clifton O. Iii Bingham</name><affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Division of Rheumatology, Johns Hopkins University</s1><s2>Baltimore, MD 21224</s2><s3>USA</s3><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>Baltimore, MD 21224</wicri:noRegion></affiliation></author><author><name sortKey="Brooks, Peter" sort="Brooks, Peter" uniqKey="Brooks P" first="Peter" last="Brooks">Peter Brooks</name><affiliation wicri:level="4"><inist:fA14 i1="09"><s1>School of Population and Global Health, University of Melbourne</s1><s2>Melbourne</s2><s3>AUS</s3><sZ>9 aut.</sZ></inist:fA14><country>Australie</country><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region><settlement type="city">Melbourne</settlement></placeName><orgName type="university">Université de Melbourne</orgName></affiliation></author><author><name sortKey="Landewe, Robert" sort="Landewe, Robert" uniqKey="Landewe R" first="Robert" last="Landewe">Robert Landewe</name><affiliation wicri:level="4"><inist:fA14 i1="10"><s1>Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam</s1><s2>Amsterdam</s2><s3>NLD</s3><sZ>10 aut.</sZ></inist:fA14><country>Pays-Bas</country><placeName><settlement type="city">Amsterdam</settlement><region nuts="2" type="province">Hollande-Septentrionale</region><settlement type="city">Amsterdam</settlement></placeName><orgName type="university">Université d'Amsterdam</orgName></affiliation></author><author><name sortKey="March, Lyn" sort="March, Lyn" uniqKey="March L" first="Lyn" last="March">Lyn March</name><affiliation wicri:level="4"><inist:fA14 i1="11"><s1>Institute of Bone and Joint Research, Kolling Institute of Medical Research, University of Sydney</s1><s2>Sydney</s2><s3>AUS</s3><sZ>11 aut.</sZ></inist:fA14><country>Australie</country><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region><settlement type="city">Sydney</settlement></placeName><orgName type="university">Université de Sydney</orgName></affiliation><affiliation wicri:level="1"><inist:fA14 i1="12"><s1>Department of Rheumatology, Royal North Shore Hospital, St. Leonards</s1><s2>New South Wales</s2><s3>AUS</s3><sZ>11 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>New South Wales</wicri:noRegion></affiliation></author><author><name sortKey="Simon, Lee S" sort="Simon, Lee S" uniqKey="Simon L" first="Lee S." last="Simon">Lee S. Simon</name><affiliation wicri:level="1"><inist:fA14 i1="13"><s1>SDG LLC</s1><s2>Cambridge, MA 02138</s2><s3>USA</s3><sZ>12 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>SDG LLC</wicri:noRegion></affiliation></author><author><name sortKey="Singh, Jasvinder A" sort="Singh, Jasvinder A" uniqKey="Singh J" first="Jasvinder A." last="Singh">Jasvinder A. Singh</name><affiliation wicri:level="1"><inist:fA14 i1="14"><s1>Division of Rheumatology, University of Alabama at Birmingham</s1><s2>Birmingham, AL 35294</s2><s3>USA</s3><sZ>13 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>Birmingham, AL 35294</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="15"><s1>Veterans Affairs Medical Center</s1><s2>Birmingham, AL 35294</s2><s3>USA</s3><sZ>13 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>Veterans Affairs Medical Center</wicri:noRegion></affiliation></author><author><name sortKey="Strand, Vibeke" sort="Strand, Vibeke" uniqKey="Strand V" first="Vibeke" last="Strand">Vibeke Strand</name><affiliation wicri:level="1"><inist:fA14 i1="16"><s1>Division of Immunology/Rheumatology, Stanford University School of Medicine</s1><s2>Palo Alto, CA 94028</s2><s3>USA</s3><sZ>14 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>Palo Alto, CA 94028</wicri:noRegion></affiliation></author><author><name sortKey="Tugwell, Peter" sort="Tugwell, Peter" uniqKey="Tugwell P" first="Peter" last="Tugwell">Peter Tugwell</name><affiliation wicri:level="1"><inist:fA14 i1="17"><s1>Department of Medicine, University of Ottawa</s1><s2>Ottawa, Ontario</s2><s3>CAN</s3><sZ>15 aut.</sZ></inist:fA14><country>Canada</country><wicri:noRegion>Ottawa, Ontario</wicri:noRegion></affiliation></author></analytic><series><title level="j" type="main">Journal of clinical epidemiology</title><title level="j" type="abbreviated">J. clin. epidemiol.</title><idno type="ISSN">0895-4356</idno><imprint><date when="2014">2014</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Journal of clinical epidemiology</title><title level="j" type="abbreviated">J. clin. epidemiol.</title><idno type="ISSN">0895-4356</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Biological marker</term><term>Clinical trial</term><term>Epidemiology</term><term>Evolution</term><term>Filter</term><term>Goal</term><term>Healthcare</term><term>Medicine</term><term>Prognosis</term><term>Public health</term><term>Reference</term><term>Rheumatology</term><term>Scientific research</term><term>Standards</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Pronostic</term><term>Evolution</term><term>Essai clinique</term><term>Filtre</term><term>Rhumatologie</term><term>Recherche scientifique</term><term>But</term><term>Marqueur biologique</term><term>Référence</term><term>Norme</term><term>Médecine</term><term>Santé publique</term><term>Epidémiologie</term><term>Soins de santé</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Recherche scientifique</term><term>Norme</term><term>Médecine</term><term>Santé publique</term><term>Soins de santé</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Background: Lack of standardization of outcome measures limits the usefulness of clinical trial evidence to inform health care decisions. This can be addressed by agreeing on a minimum core set of outcome measures per health condition, containing measures relevant to patients and decision makers. Since 1992, the Outcome Measures in Rheumatology (OMERACT) consensus initiative has successfully developed core sets for many rheumatologic conditions, actively involving patients since 2002. Its expanding scope required an explicit formulation of its underlying conceptual framework and process. Methods: Literature searches and iterative consensus process (surveys and group meetings) of stakeholders including patients, health professionals, and methodologists within and outside rheumatology. Results: To comprehensively sample patient-centered and intervention-specific outcomes, a framework emerged that comprises three core "Areas," namely Death, Life Impact, and Pathophysiological Manifestations; and one strongly recommended Resource Use. Through literature review and consensus process, core set development for any specific health condition starts by identifying at least one core "Domain" within each of the Areas to formulate the "Core Domain Set." Next, at least one applicable measurement instrument for each core Domain is identified to formulate a "Core Outcome Measurement Set." Each instrument must prove to be truthful (valid), discriminative, and feasible. In 2012, 96% of the voting participants (n = 125) at the OMERACT 11 consensus conference endorsed this model and process. Conclusion: The OMERACT Filter 2.0 explicitly describes a comprehensive conceptual framework and a recommended process to develop core outcome measurement sets for rheumatology likely to be useful as a template in other areas of health care.</div></front></TEI><affiliations><list><country><li>Australie</li><li>Canada</li><li>France</li><li>Pays-Bas</li><li>Royaume-Uni</li><li>États-Unis</li></country><region><li>Angleterre</li><li>Hollande-Septentrionale</li><li>Nouvelle-Galles du Sud</li><li>Ontario</li><li>Victoria (État)</li><li>Yorkshire-et-Humber</li><li>Île-de-France</li></region><settlement><li>Amsterdam</li><li>Boulogne-Billancourt</li><li>Leeds</li><li>Melbourne</li><li>Paris</li><li>Sydney</li><li>Toronto</li></settlement><orgName><li>Université Pierre-et-Marie-Curie</li><li>Université d'Amsterdam</li><li>Université de Leeds</li><li>Université de Melbourne</li><li>Université de Sydney</li><li>Université de Toronto</li></orgName></list><tree><country name="Pays-Bas"><noRegion><name sortKey="Boers, Maarten" sort="Boers, Maarten" uniqKey="Boers M" first="Maarten" last="Boers">Maarten Boers</name></noRegion><name sortKey="Landewe, Robert" sort="Landewe, Robert" uniqKey="Landewe R" first="Robert" last="Landewe">Robert Landewe</name></country><country name="Royaume-Uni"><noRegion><name sortKey="Kirwan, John R" sort="Kirwan, John R" uniqKey="Kirwan J" first="John R." last="Kirwan">John R. Kirwan</name></noRegion><name sortKey="Conaghan, Philip G" sort="Conaghan, Philip G" uniqKey="Conaghan P" first="Philip G." last="Conaghan">Philip G. Conaghan</name></country><country name="Canada"><noRegion><name sortKey="Wells, George" sort="Wells, George" uniqKey="Wells G" first="George" last="Wells">George Wells</name></noRegion><name sortKey="Beaton, Dorcas" sort="Beaton, Dorcas" uniqKey="Beaton D" first="Dorcas" last="Beaton">Dorcas Beaton</name><name sortKey="Tugwell, Peter" sort="Tugwell, Peter" uniqKey="Tugwell P" first="Peter" last="Tugwell">Peter Tugwell</name></country><country name="France"><region name="Île-de-France"><name sortKey="Gossec, Laure" sort="Gossec, Laure" uniqKey="Gossec L" first="Laure" last="Gossec">Laure Gossec</name></region><name sortKey="D Agostino, Maria Antonietta" sort="D Agostino, Maria Antonietta" uniqKey="D Agostino M" first="Maria-Antonietta" last="D'Agostino">Maria-Antonietta D'Agostino</name></country><country name="États-Unis"><noRegion><name sortKey="Bingham, Clifton O Iii" sort="Bingham, Clifton O Iii" uniqKey="Bingham C" first="Clifton O. Iii" last="Bingham">Clifton O. Iii Bingham</name></noRegion><name sortKey="Simon, Lee S" sort="Simon, Lee S" uniqKey="Simon L" first="Lee S." last="Simon">Lee S. Simon</name><name sortKey="Singh, Jasvinder A" sort="Singh, Jasvinder A" uniqKey="Singh J" first="Jasvinder A." last="Singh">Jasvinder A. Singh</name><name sortKey="Singh, Jasvinder A" sort="Singh, Jasvinder A" uniqKey="Singh J" first="Jasvinder A." last="Singh">Jasvinder A. Singh</name><name sortKey="Strand, Vibeke" sort="Strand, Vibeke" uniqKey="Strand V" first="Vibeke" last="Strand">Vibeke Strand</name></country><country name="Australie"><region name="Victoria (État)"><name sortKey="Brooks, Peter" sort="Brooks, Peter" uniqKey="Brooks P" first="Peter" last="Brooks">Peter Brooks</name></region><name sortKey="March, Lyn" sort="March, Lyn" uniqKey="March L" first="Lyn" last="March">Lyn March</name><name sortKey="March, Lyn" sort="March, Lyn" uniqKey="March L" first="Lyn" last="March">Lyn March</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004208 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004208 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= Pascal:14-0220648
|texte= Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0
}}
| This area was generated with Dilib version V0.6.33. |  |